Prospective Randomized Study of Sarpogrelate Versus Clopidogrel-based Dual Antiplatelet Therapies in Patients Undergoing Femoropopliteal Arterial Endovascular Interventions： Preliminary Results

Background：Sarpogrelate is a selective 5-hydroxytryptamine （5-HT） receptor subtype 2A antagonist which blocks 5-HT induced platelet aggregation and proliferation of vascular smooth muscle cells.We compared the efficacy of sarpogrelate-based dual antiplatelet therapies for the prevention of restenosi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Chinese medical journal 2015-06, Vol.128 (12), p.1563-1566
Hauptverfasser:	Chen, Yue-Xin, Wang, Wen-Da, Song, Xiao-Jun, Gu, Yong-Quan, Tian, Hong-Yan, Hu, He-Jie, Zhao, Ji-Chun, Li, Xiao-Qiang, Liu, Chang-Wei
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Angioplasty Arterial Occlusive Diseases - drug therapy Aspirin Cell growth Classification Clinical medicine Clinical trials Complications and side effects Dosage and administration Drug therapy Female Fibrinolytic Agents - therapeutic use Hospitals Humans Kaplan-Meier Estimate Male Middle Aged Original Patients Peripheral Vascular Diseases - drug therapy Physicians Platelet aggregation inhibitors Popliteal Artery - drug effects Popliteal Artery - pathology Serotonin Serotonin Antagonists - therapeutic use Smooth muscle Stents Succinates - therapeutic use Ticlopidine - analogs & derivatives Ticlopidine - therapeutic use Ultrasonic imaging Vascular diseases Vascular surgery Veins & arteries 介入治疗动脉双联患者氯吡格雷管内血小板聚集随机
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!